Advanced search
Publication Cover
OncoImmunology Volume 12, 2023 - Issue 1
Submit an article Journal homepage
2,709
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1

Debayan Mukherjeea Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UKView further author information
,
Erminia Romanoa Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UKView further author information
,
Richard Walshawa Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UKView further author information
,
Leo A. H. Zeefb Bioinformatics Core Facility, Michael Smith Building, The University of Manchester, Manchester, UKView further author information
,
Antonia Banyardc Mass and Flow Cytometry Core Facility, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UKView further author information
,
Stephen J. Kitcattd Scientific Computing Core Facility, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UKView further author information
,
Eleanor J. Cheadlea Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UKView further author information
,
Karoliina Tuomelaa Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UKView further author information
,
Swati Pendharkara Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UKView further author information
,
Aws Al-Dekaa Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UKView further author information
,
Beatrice Salernoa Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UKView further author information
,
Sophie Rabya Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UKView further author information
,
Ian G. Millse Nuffield Department of Surgical Sciences, John Radcliffe Hospital, University of Oxford, Oxford, UK;f Patrick G. Johnston Centre for Cancer Research, Queen’s University of Belfast, Belfast, UKView further author information
,
Jamie Honeychurcha Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UKCorrespondence[email protected]
View further author information
&
Tim M. Illidgea Targeted Therapy Group, Division of Cancer Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UKCorrespondence[email protected]
View further author information
 show all
Article: 2223094 | Received 30 Jan 2023, Accepted 06 Jun 2023, Published online: 15 Jun 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.